vs
GEN Restaurant Group, Inc.(GENK)与RIGEL PHARMACEUTICALS INC(RIGL)财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是GEN Restaurant Group, Inc.的1.4倍($69.8M vs $49.7M),RIGEL PHARMACEUTICALS INC净利率更高(384.0% vs -3.8%,领先387.9%),RIGEL PHARMACEUTICALS INC同比增速更快(21.2% vs -9.0%),过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高(53.7% vs -1.0%)
GEN韩式烤肉是美国的韩式烤肉自助连锁品牌,门店主要集中于美国西部地区,品牌创立于2011年,截至2024年已发展至43家门店,主打任食韩式烤肉产品,在当地拥有较高的知名度。
Rigel制药是一家临床阶段生物技术企业,专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法,核心市场位于美国,旗下已获批产品可治疗成人免疫性血小板减少症,致力于满足未被覆盖的临床医疗需求。
GENK vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.4倍
$49.7M
营收增速更快
RIGL
高出30.2%
-9.0%
净利率更高
RIGL
高出387.9%
-3.8%
两年增速更快
RIGL
近两年复合增速
-1.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $49.7M | $69.8M |
| 净利润 | $-1.9M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | -24.5% | 33.2% |
| 净利率 | -3.8% | 384.0% |
| 营收同比 | -9.0% | 21.2% |
| 净利润同比 | -821.4% | 1769.2% |
| 每股收益(稀释后) | $-0.37 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
GENK
RIGL
| Q4 25 | $49.7M | $69.8M | ||
| Q3 25 | $50.4M | $69.5M | ||
| Q2 25 | $55.0M | $101.7M | ||
| Q1 25 | $57.3M | $53.3M | ||
| Q4 24 | $54.7M | $57.6M | ||
| Q3 24 | $49.1M | $55.3M | ||
| Q2 24 | $53.9M | $36.8M | ||
| Q1 24 | $50.8M | $29.5M |
净利润
GENK
RIGL
| Q4 25 | $-1.9M | $268.1M | ||
| Q3 25 | $-566.0K | $27.9M | ||
| Q2 25 | $-261.0K | $59.6M | ||
| Q1 25 | $-301.0K | $11.4M | ||
| Q4 24 | $-206.0K | $14.3M | ||
| Q3 24 | $25.0K | $12.4M | ||
| Q2 24 | $277.0K | $-1.0M | ||
| Q1 24 | $496.0K | $-8.2M |
毛利率
GENK
RIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率
GENK
RIGL
| Q4 25 | -24.5% | 33.2% | ||
| Q3 25 | -7.4% | 40.9% | ||
| Q2 25 | -3.4% | 60.1% | ||
| Q1 25 | -3.8% | 23.9% | ||
| Q4 24 | -2.4% | 28.9% | ||
| Q3 24 | 0.2% | 25.4% | ||
| Q2 24 | 3.0% | 1.2% | ||
| Q1 24 | 0.2% | -23.6% |
净利率
GENK
RIGL
| Q4 25 | -3.8% | 384.0% | ||
| Q3 25 | -1.1% | 40.2% | ||
| Q2 25 | -0.5% | 58.6% | ||
| Q1 25 | -0.5% | 21.5% | ||
| Q4 24 | -0.4% | 24.9% | ||
| Q3 24 | 0.1% | 22.5% | ||
| Q2 24 | 0.5% | -2.8% | ||
| Q1 24 | 1.0% | -27.9% |
每股收益(稀释后)
GENK
RIGL
| Q4 25 | $-0.37 | $14.11 | ||
| Q3 25 | $-0.11 | $1.46 | ||
| Q2 25 | $-0.05 | $3.28 | ||
| Q1 25 | $-0.06 | $0.63 | ||
| Q4 24 | $-0.05 | $0.82 | ||
| Q3 24 | $0.01 | $0.70 | ||
| Q2 24 | $0.06 | $-0.06 | ||
| Q1 24 | $0.11 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $2.8M | $155.0M |
| 总债务越低越好 | $13.6M | $52.5M |
| 股东权益账面价值 | $26.5M | $391.5M |
| 总资产 | $259.9M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.51× | 0.13× |
8季度趋势,按日历期对齐
现金及短期投资
GENK
RIGL
| Q4 25 | $2.8M | $155.0M | ||
| Q3 25 | $4.8M | $137.1M | ||
| Q2 25 | $9.6M | $108.4M | ||
| Q1 25 | $15.4M | $77.1M | ||
| Q4 24 | $23.7M | $77.3M | ||
| Q3 24 | $22.1M | $61.1M | ||
| Q2 24 | $29.2M | $49.1M | ||
| Q1 24 | $28.1M | $49.5M |
总债务
GENK
RIGL
| Q4 25 | $13.6M | $52.5M | ||
| Q3 25 | $10.8M | $60.0M | ||
| Q2 25 | $7.8M | $60.0M | ||
| Q1 25 | $6.5M | $60.0M | ||
| Q4 24 | $6.9M | $60.0M | ||
| Q3 24 | $7.2M | $60.0M | ||
| Q2 24 | $7.6M | $60.0M | ||
| Q1 24 | $7.7M | $60.0M |
股东权益
GENK
RIGL
| Q4 25 | $26.5M | $391.5M | ||
| Q3 25 | $38.1M | $117.6M | ||
| Q2 25 | $41.0M | $81.9M | ||
| Q1 25 | $42.8M | $18.6M | ||
| Q4 24 | $44.1M | $3.3M | ||
| Q3 24 | $46.5M | $-14.6M | ||
| Q2 24 | $45.9M | $-29.9M | ||
| Q1 24 | $40.4M | $-31.7M |
总资产
GENK
RIGL
| Q4 25 | $259.9M | $513.6M | ||
| Q3 25 | $245.5M | $242.5M | ||
| Q2 25 | $246.3M | $206.7M | ||
| Q1 25 | $232.4M | $176.0M | ||
| Q4 24 | $240.4M | $164.0M | ||
| Q3 24 | $225.7M | $139.4M | ||
| Q2 24 | $218.8M | $128.4M | ||
| Q1 24 | $214.5M | $126.5M |
负债/权益比
GENK
RIGL
| Q4 25 | 0.51× | 0.13× | ||
| Q3 25 | 0.28× | 0.51× | ||
| Q2 25 | 0.19× | 0.73× | ||
| Q1 25 | 0.15× | 3.23× | ||
| Q4 24 | 0.16× | 18.25× | ||
| Q3 24 | 0.16× | — | ||
| Q2 24 | 0.17× | — | ||
| Q1 24 | 0.19× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-426.0K | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-5.6M | — |
| 自由现金流率自由现金流/营收 | -11.3% | — |
| 资本支出强度资本支出/营收 | 10.5% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-24.3M | — |
8季度趋势,按日历期对齐
经营现金流
GENK
RIGL
| Q4 25 | $-426.0K | $22.0M | ||
| Q3 25 | $-1.6M | $24.0M | ||
| Q2 25 | $3.3M | $30.5M | ||
| Q1 25 | $2.2M | $-893.0K | ||
| Q4 24 | $7.3M | $14.5M | ||
| Q3 24 | $1.4M | $21.7M | ||
| Q2 24 | $5.6M | $302.0K | ||
| Q1 24 | $3.5M | $-5.0M |
自由现金流
GENK
RIGL
| Q4 25 | $-5.6M | — | ||
| Q3 25 | $-7.7M | — | ||
| Q2 25 | $-6.3M | — | ||
| Q1 25 | $-4.7M | — | ||
| Q4 24 | $165.0K | — | ||
| Q3 24 | $-6.8M | — | ||
| Q2 24 | $1.2M | — | ||
| Q1 24 | $-586.0K | — |
自由现金流率
GENK
RIGL
| Q4 25 | -11.3% | — | ||
| Q3 25 | -15.3% | — | ||
| Q2 25 | -11.5% | — | ||
| Q1 25 | -8.2% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | -13.9% | — | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | -1.2% | — |
资本支出强度
GENK
RIGL
| Q4 25 | 10.5% | — | ||
| Q3 25 | 12.0% | — | ||
| Q2 25 | 17.5% | — | ||
| Q1 25 | 11.9% | — | ||
| Q4 24 | 13.1% | — | ||
| Q3 24 | 16.9% | — | ||
| Q2 24 | 8.0% | — | ||
| Q1 24 | 8.1% | — |
现金转化率
GENK
RIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 57.96× | 1.75× | ||
| Q2 24 | 20.06× | — | ||
| Q1 24 | 7.08× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图